AEMETIS, INC

For the period ended Dec 31, 2024. Filed Mar 14, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 14, 2025

AMTX$1.59-8.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders' Deficit

(In thousands)

Series B Preferred Stock · Common Stock · Additional Paid-in · Accumulated · Accumulated Other Comprehensive
Shares · Dollars · Shares · Dollars · Capital · Deficit · Loss · Total
Balance at December 31, 2022	1,270		$1	35,869	$36	$232,546	$(428,985)	$(5,452)	$(201,854)
Issuance of common stock	-		-	4,499	4	21,714	-	-	21,718
Series B conversion to common stock	(1,270)		(1)	127	1	-	-	-	-
Stock options exercised	-		-	183	-	133	-	-	133
Stock-based compensation	-		-	-	-	7,660	-	-	7,660
Issuance and exercise of warrants	-		-	288	-	2,005	-	-	2,005
Foreign currency translation loss	-		-	-	-	-	-	(219)	(219)
Net loss	-		-	-	-	-	(46,420)	-	(46,420)
Balance at December 31, 2023	-		-	40,966	41	264,058	(475,405)	(5,671)	(216,977)
Issuance of common stock	-		-	9,933	10	32,005	-	-	32,015
Stock options exercised	-		-	14	-	36	-	-	36
Stock-based compensation	-		-	-	-	8,314	-	-	8,314
Issuance and exercise of warrants	-		-	226	-	916	-	-	916
Foreign currency translation loss	-		-	-	-	-	-	(695)	(695)
Net loss	-		-	-	-	-	(87,537)	-	(87,537)
Balance at December 31, 2024	-	$	-	51,139	$51	305,329	$(562,942)	$(6,366)	$(263,928)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.